Gynapss Pharmaceuticals Priavte Limited - Company Profile

It is a chemicals private limited company based in Varanasi, Uttar Pradesh, India, established in 2021.
2021 Varanasi, Uttar Pradesh, India Active
Last Updated:
About Gynapss Pharmaceuticals Priavte Limited

Gynapss Pharmaceuticals Priavte Limited, a active private limited company, was established on 10 June 2021 in Varanasi, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230UP2021PTC147138. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Aarti Devi (Managing Director), Sharda Rani (Director). It is based at House No 96 Akhri Kurahua By Pass Road Varanasi, Varanasi Uttar Pradesh-221011, Varanasi, Uttar Pradesh, 221011.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230UP2021PTC147138

  • Registration Number

    147138

  • Incorporation Date

    10 June 2021

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 4 Year, 8 Months
Company report

Gynapss Pharmaceuticals Priavte Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gynapss Pharmaceuticals Priavte Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gynapss Pharmaceuticals Priavte Limited?
Current Directors
Name Designation Appointment Date Status
Aarti Devi Managing Director 10 Jun 2021 Current
Sharda Rani Director 10 Jun 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gynapss Pharmaceuticals Priavte.

Enhance accessibility to Gynapss Pharmaceuticals Priavte's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gynapss Pharmaceuticals Priavte revenue growth over time
Gynapss Pharmaceuticals Priavte profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gynapss Pharmaceuticals Priavte?

Unlock access to Gynapss Pharmaceuticals Priavte's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gynapss Pharmaceuticals Priavte?

Gynapss Pharmaceuticals Priavte has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gynapss Pharmaceuticals Priavte, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gynapss Pharmaceuticals Priavte's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gynapss Pharmaceuticals Priavte
Recent Activity within the Organization
  • Director Appointment

    The activity Aarti Devi was appointed as a Managing Director was appointed as a Managing Director on 10 Jun 2021 & has been associated with this company since 4 years 8 months . was completed.

  • Director Appointment

    The activity Sharda Rani was appointed as a Director was appointed as a Director on 10 Jun 2021 & has been associated with this company since 4 years 8 months . was completed.

  • Company Incorporation

    Gynapss Pharmaceuticals Priavte Limited was registered on 10 Jun 2021 with Roc Kanpur & aged 4 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gynapss Pharmaceuticals Priavte Limited?

The CIN of Gynapss Pharmaceuticals Priavte Limited is U24230UP2021PTC147138.

Where is Gynapss Pharmaceuticals Priavte Limited headquartered?

Gynapss Pharmaceuticals Priavte Limited is headquartered at House No 96 Akhri Kurahua By Pass Road Varanasi, Varanasi Uttar Pradesh-221011, Varanasi, Uttar Pradesh, 221011.

When was Gynapss Pharmaceuticals Priavte Limited incorporated?

Gynapss Pharmaceuticals Priavte Limited was incorporated on 10 June 2021.

Who are the current directors of Gynapss Pharmaceuticals Priavte Limited?

The current directors of Gynapss Pharmaceuticals Priavte Limited are

What is the primary industry of Gynapss Pharmaceuticals Priavte Limited?

The primary industry of Gynapss Pharmaceuticals Priavte Limited is Chemicals.

Is Gynapss Pharmaceuticals Priavte Limited a listed company?

Gynapss Pharmaceuticals Priavte Limited is unlisted.

What is the capital structure of Gynapss Pharmaceuticals Priavte Limited?

The authorized capital of Gynapss Pharmaceuticals Priavte Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available